Xiaojun Yu

Xiaojun Yu


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
ZYZhimeng Yao
Zhimeng Yao
HDHong-Mei Dong
Hong-Mei Dong
JZJianlin Zhu
Jianlin Zhu
LDLiang Du
Liang Du
YLYichen Luo
Yichen Luo
HZHao Zhang
Hao Zhang
Chemotherapy-related cognitive impairment (CRCI) or “chemo brain” is a devastating neurotoxic sequela of cancer-related treatments, especially for the elderly individuals. Here we show that PTPRO, a tyrosine phosphatase, is highly enriched in the hippocampus, and its level is tightly associated with neurocognitive function but declined significantly during aging. To understand the protective role of PTPRO in CRCI, a mouse model was generated by treating Ptpro –/– female mice with doxorubicin (DOX) because Ptpro –/– female mice are more vulnerable to DOX, showing cognitive impairments and neurodegeneration. By analyzing PTPRO substrates that are neurocognition-associated tyrosine kinases, we found that SRC and EPHA4 are highly phosphorylated/activated in the hippocampi of Ptpro –/– female mice, with increased sensitivity to DOX-induced CRCI. On the other hand, restoration of PTPRO in the hippocampal CA3 region significantly ameliorate CRCI in Ptpro –/– female mice. In addition, we found that the plant alkaloid berberine (BBR) is capable of ameliorating CRCI in aged female mice by upregulating hippocampal PTPRO. Mechanistically, BBR upregulates PTPRO by downregulating miR-25-3p, which directly targeted PTPRO. These findings collectively demonstrate the protective role of hippocampal PTPRO against CRCI.

10 January 2015 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
GXGuangtao Xu
Guangtao Xu
BHBo Hu
Bo Hu
GCGuiqian Chen
Guiqian Chen
XYXiaojun Yu
Xiaojun Yu
JLJianming Luo
Jianming Luo
JGJiang Gu
Jiang Gu

5 June 2015 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
GXGuangtao Xu
Guangtao Xu
RSRuibing Su
Ruibing Su
BLBo Li
Bo Li
JLJunyao Lv
Junyao Lv
WSWeiqi Sun
Weiqi Sun
XYXiaojun Yu
Xiaojun Yu

2 January 2017 in Forensic Sciences Research
Verified
Journal Article
Open access
XLXianxian Li
Xianxian Li
GXGuangtao Xu
Guangtao Xu
RSRuibing Su
Ruibing Su
JLJunyao Lv
Junyao Lv
XLXiaoping Lai
Xiaoping Lai
XYXiaojun Yu
Xiaojun Yu
Intramedullary schwannoma of the upper cervical spinal cord is rarely reported in forensic medicine. We herein report a case involving a patient who died of compression from an intramedullary schwannoma in the upper cervical spinal cord. A 30-year-old man initially presented with a five-day history of pain in the left chest that progressed to weakening in the left arm. Although the patient was treated with analgesic poultices, he developed inspiratory dyspnoea and died while working the next day without having undergone any medical imaging examination or surgical treatment. Anatomical and histopathological examinations revealed an intramedullary schwannoma in the left cervical spinal cord (C3–C5) underneath the spinal nerve root. The cause of death might have been asphyxia secondary to the tumour, which interfered with the nerve function in the respiratory muscles. This finding suggests that an autopsy is essential for pathologists and medicolegists to comprehensively undertake their due obligation to obtain “the first evidence”, especially when there is a lack of directly related evidence. As part of the central nervous system, the spinal cord could be systematically included in a routine pathological autopsy in some cases.

17 October 2016 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
GXGuangtao Xu
Guangtao Xu
RSRuibing Su
Ruibing Su
JLJunyao Lv
Junyao Lv
XLXiaoping Lai
Xiaoping Lai
XLXianxian Li
Xianxian Li
XYXiaojun Yu
Xiaojun Yu

17 August 2018 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
YZYongxia Zheng
Yongxia Zheng
JZJiansheng Zhou
Jiansheng Zhou
XLXuebo Li
Xuebo Li
GXGuangtao Xu
Guangtao Xu
MJMingliang Jin
Mingliang Jin
XYXiaojun Yu
Xiaojun Yu
Background/Aims: Liver progenitor cells (LPCs) were considered as a promising hepatocyte source of cell therapy for liver disease due to their self-renewal and differentiation capacities, while little is known about the mechanism of LPC differentiate into hepatocytes. This study aims to explore the effect of miR-382, a member of Dlk1-Dio3 microRNA cluster, during hepatic differentiation from LPCs. Methods: In this study, we used rat liver progenitor cell WB-F344 as LPC cell model and HGF as inducer to simulate the process of LPCs hepatic differentiation, then microRNAs were quantified by qPCR. Next, WB-F344 cell was transfected with miR-382 mimics, then hepatocyte cell trait was characterized by multiple experiments, including that periodic acid schiff staining and cellular uptake and excretion of indocyanine green to evaluate the hepatocellular function, qPCR and Western Blotting analysis to detect the hepatocyte-specific markers (ALB, Ttr, Apo E and AFP) and transmission electron microscopy to observe the hepatocellular morphology. Moreover, Luciferase reporter assay was used to determine whether Ezh2 is the direct target of miR-382. Results: We found that miR-382 increased gradually and was inversely correlated with the potential target, Ezh2, during WB-F344 hepatic differentiation. In addition, functional studies indicated that miR-382 increased the level of hepatocyte-specific genes. Conclusions: This study demonstrates that miR-382 may be a novel regulator of LPCs differentiation by targeting Ezh2.